Specialty code 174400000X · Asheboro, NC
NPI
1508059247
Since 2007
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
230 Foust St
Asheboro, NC, 27203
Phone (336) 633-0407
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$357K
7,188 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Dwight M Williams prescribed most often to Medicare patients was Oxycodone Hcl, with 643 prescriptions and refills. In total Dwight M Williams wrote 7,188 Medicare prescriptions that cost $357K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Oxycodone Hcl Generic | 643 | 643 | 57 | $12K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 453 | 453 | 43 | $15K |
| Alprazolam Generic | 339 | 339 | 30 | $930 |
| Gabapentin Generic | 301 | 303 | 32 | $2,647 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 206 | 234 | 39 | $5,959 |
| Furosemide Generic | 176 | 234 | 30 | $464 |
| Omeprazole Generic | 173 | 249 | 25 | $976 |
| Amlodipine Besylate Generic | 137 | 229 | 28 | $290 |
| Promethazine Hcl Generic | 133 | 133 | 17 | $844 |
| Atorvastatin Calcium Generic | 121 | 245 | 27 | $655 |
| Potassium Chloride Generic | 120 | 153 | 23 | $1,121 |
| Cyclobenzaprine Hcl Generic | 114 | 114 | 15 | $353 |
| Levothyroxine Sodium Generic | 111 | 195 | 18 | $718 |
| Pantoprazole Sodium Generic | 111 | 181 | 20 | $512 |
| Montelukast Sodium Generic | 101 | 140 | 15 | $388 |
Brand drugs: 749 claims; generic drugs: 6,411 claims; opioid claims: 1,196.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Dwight M Williams were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.